
Allergy/Immunology specialist at the Allergy and Asthma Center in Las Vegas, NV & Clinical Assistant Professor of Internal Medicine and Pediatrics @unrmed
Las Vegas, NV
Joined April 2011
- Tweets4.7K
- Following3K
- Followers2.4K
- Likes1.4K
Impressive Phase 3 data for tozorakimab in COPD: ~30% fewer moderate/severe exacerbations, with an event-based NNT ≈1.7 patient-years. A potentially important new option for high-risk COPD. #COPD #NEJM
nejm.org/doi/full/10.1056/NE…
1
74
Jason Bellak, MD, FAAAAI, FACAAI, FACP retweeted
Sometimes you don’t even know when you’ve already watched the end.
You had to be there. And now it’s over.
Jason Bellak, MD, FAAAAI, FACAAI, FACP retweeted
Hypereosinophilia and Hypereosinophilic Syndromes: First Findings From a Nationwide Multicenter Cohort. Corresponding author: Guillaume Lefèvre
Read the article here: doi.org/10.1111/all.16463
The COHESion study is the first prospective large-scale multicenter study dedicated to all hypereosinophilia/hypereosinophilic syndrome (HE/HES) subtypes. The final diagnoses were idiopathic HES (HES-I, 47%), HE/HES-reactive (16%), HE-uncertain significance (15%), HE/HES-neoplastic (7%), HE/HES-lymphocytic (6%), IgG4-related disease (2%), and antineutrophil cytoplasmic antibody-negative eosinophilic granulomatosis with polyangiitis (EGPA) (7%). Considering all HES subtypes, the most frequent symptoms were cutaneous, respiratory and digestive symptoms (42%, 30% and 25%, respectively) followed by cardiac manifestations, vascular manifestations and ear, nose, throat (ENT) symptoms (12%, 9% and 7%, respectively).
#Allergy_journal
Read more articles published in #Allergy on clinical immunology here: journalallergy.com/Autoimmun…
Omalizumab Is Superior to Oral Immunotherapy Food Allergy. OIT has more potential for side effects. However, other, safer forms of food immunotherapy such as SLIT may be a better option for some. aaaai.org/about/news/news/20…
1
6
326
Trends in Phenylephrine and Pseudoephedrine Sales in the US jamanetwork.com/journals/jam…
1
161
Jason Bellak, MD, FAAAAI, FACAAI, FACP retweeted
Now enrolling: A peanut allergy study is testing an investigational tablet containing peanut protein that dissolves under the tongue for individuals ages 4 to 65. See if you or your child may qualify. Contact [email protected]
Jason Bellak, MD, FAAAAI, FACAAI, FACP retweeted
Researchers at @ucsfmicrobiome at Parnassus Heights are working to prevent childhood asthma using CRISPR gene editing to alter the gut microbiome.
tiny.ucsf.edu/uX55QV
Dupilumab for COPD with Type 2 Inflammation Indicated by Eosinophil Counts | NEJM nejm.org/doi/full/10.1056/NE…
214
I am thrilled to announce that I am the new owner of the Allergy and Asthma Center in my hometown of Las Vegas! I am honored and blessed to be able carry on the legacy of care that Dr. Joel Katz provided to patients. Two wonderful years in Reno--thank you colleagues and patients!
Jason Bellak, MD, FAAAAI, FACAAI, FACP retweeted
Long Live the Fighters. #DunePartTwo only in theaters November 3.
Dune: Part Two | Official Trailer
Jason Bellak, MD, FAAAAI, FACAAI, FACP retweeted
In a 10-year period, Las Vegas will have added:
The A's
The Aces
The Raiders
The Desert Dogs
The Golden Knights
The Pro Bowl
A Super Bowl
An NFL Draft
A Final Four
A Formula 1 Grand Prix
A CFP National Championship
Jason Bellak, MD, FAAAAI, FACAAI, FACP retweeted
I will be closing down my Twitter in 2 weeks. Meanwhile:
My Transplanted Heart and I Will Die Soon nytimes.com/2023/04/18/opini…
Jason Bellak, MD, FAAAAI, FACAAI, FACP retweeted
We've had a number of drug shortages here in #Canada as well including many commonly prescribed #inhalers #antihistamines not to mention OTC products. Hopefully the supply chain issues and other factors will be addressed soon! @AAAAI_org #Albuterolshortage #MedTwitter
Our new episode is live: The Albuterol Shortage & What it Means for Patients. Basil Kahwash MD, provides background, perspective & reassurance on the shortage of liquid albuterol. This is for anyone who relies on albuterol for treatment. #asthma #albuterol
ow.ly/4wZk50Nk52B
Nonhuman “Authors” and Implications for the Integrity of Scientific Publication and Medical Knowledge ja.ma/3HJHmbU via @JAMA_current part of @JAMANetwork
119
Coronavirus (COVID-19) Update: FDA Authorizes Drug for Treatment of COVID-19 fda.gov/news-events/press-an…
98
Jason Bellak, MD, FAAAAI, FACAAI, FACP retweeted
Northstar received 27 inches of new snow overnight. This is significant and will likely cause lift and terrain delays. Please ski and snowboard with a friend and keep an eye on our updates. Thank you for your patience! (1/2)
Jason Bellak, MD, FAAAAI, FACAAI, FACP retweeted
Forecasts for the 9th-17th AFTER the storms through the weekend...
Jason Bellak, MD, FAAAAI, FACAAI, FACP retweeted
Our new paper re early introduction of peanut, combining all LEAP and EAT Study cohorts - well done all - sciencedirect.com/science/ar…



















